Profound Medical Corp. filed a Form 8-K with the SEC on August 17, 2026, disclosing the introduction of the company's new real-time interventional MRI Software via a press release issued the same day.

Key Highlights

  • New product announcement: Profound Medical Corp. announced the introduction of its new real-time interventional MRI Software on August 17, 2026.
  • Disclosure method: The announcement was made through a press release furnished as Exhibit 99.1 to the filing.
  • Regulation FD: The disclosure was made under Item 7.01, Regulation FD Disclosure.
  • Not deemed "filed": According to the filing, the information furnished under Item 7.01, including Exhibit 99.1, "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934."
  • Signed by: The filing was signed by Arun Menawat, Chief Executive Officer and Chairman of Profound Medical Corp.

Profound Medical Discloses Real-Time Interventional MRI Software Introduction

Profound Medical Corp. (NASDAQ:PROF), incorporated in Ontario, Canada, and headquartered at 2400 Skymark Avenue, Unit 6, Mississauga, Ontario, filed a current report on August 17, 2026, reporting under Item 7.01, Regulation FD Disclosure. According to the filing, the company issued a press release on that date announcing "the introduction of the Company's new real-time interventional MRI Software."

The filing notes that the press release is furnished as Exhibit 99.1 and specifies that the information disclosed under Item 7.01 "shall not be deemed incorporated by reference into any other filing with the U.S. Securities Exchange Commission, or the SEC, made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing." The filing does not contain additional technical details about the software beyond the announcement of its introduction.

Arun Menawat, Chief Executive Officer and Chairman, signed the filing on behalf of Profound Medical Corp. The company's common shares, with no par value per share, are listed on The Nasdaq Stock Market under the trading symbol PROF. Profound Medical Corp. is not classified as an emerging growth company, as indicated on the filing's cover page.

What Was Disclosed

Profound Medical Corp. reported the introduction of its new real-time interventional MRI Software through a Regulation FD disclosure filed on August 17, 2026. The related press release was furnished as Exhibit 99.1 and is not deemed "filed" under the Securities Exchange Act.